Belgium· BE-AMP-SAM217576-00
Videx EC 200 mg
A didanosine product containing didanosine, registered in Belgium by Bristol-Myers Squibb Belgium. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Didanosine is registered in 3 of 19 countries.
Countries holding a registration under ATC J05AF02 (didanosine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Didanosine · ATC J05AF02
3 / 19 countries
- Belgiumprice
- Finlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Didanosine
- Manufacturer
- Bristol-Myers Squibb Belgium
- Country
- Belgium (BE)
- ATC code
- J05AF02
- ATC class
- Didanosine
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb1580489
- be_apb0767319
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
196 interactions on record for didanosine.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Didanosine · interactions on record
196 records
- 8 severe
- 97 moderate
- 7 minor
- 84 info
Most severe, free to view
- BexaroteneL01XF03severe
- HydroxycarbamideL01XX05severe
- BexarotenL01XX25severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Didanosine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/24cb77c7-37be-4f6a-93b0-ae4f491556bd GET /v1/drugs/24cb77c7-37be-4f6a-93b0-ae4f491556bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Gastro-resistant capsule, hard",
"source": "afmps",
"status": "REVOKED",
"name_en": "Videx EC 200 mg",
"name_fr": "Videx EC 200 mg",
"name_nl": "Videx EC 200 mg",
"amp_code": "SAM217576-00",
"strengths": [
"200.0000"
],
"pack_count": 2,
"substances": [
"Didanosine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Didanosine",
"authorisation_numbers": [
"BE217576"
]
}See everything about didanosine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.